Search for: "Ely Lilly" Results 1501 - 1520 of 2,157
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Feb 2014, 3:18 pm by Ronald V. Miller, Jr.
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
16 Apr 2014, 5:35 am by Ronald V. Miller, Jr.
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Researchers have long suspected a link between testosterone treatment and the risk of heart attack, though millions of men who have been taking the hormonal treatments are just now… [read post]
13 Jan 2010, 2:47 am by Adam Kolber
In 2008 a team led by Heilig reported that an experimental drug called LY686017, made by Eli Lilly, suppressed cravings for alcohol in a small group of recently detoxified alcoholics (Science, vol 319, p 1536). [read post]
19 Jul 2007, 1:45 pm
Concerns by 3M Eli Lilly, General Electric, Johnson & Johnson and Proctor & Gamble were muted after amendments to the bill narrowed the “second window” of post-grant reviews. [read post]
21 May 2007, 3:26 pm
REHEARING BRIEFS: Pfizer's Petition for Rehearing Amicus Brief of SmithKline Beecham and Eli Lilly Amicus Brief of BIO Amicus Brief of PhRMA Amicus Brief of Mylan Labs Apotex's Answer to Pfizer's Petition RELATED READING: Patent Docs Reuters [read post]
1 Aug 2013, 9:29 am by Derek T. Braslow
• Liraglutide (Victoza) marketed by Novo Nordisk • Sitagliptin (Januvia, Janumet & Juvisync) marketed by Merck • Saxagliptin (Onglyza & Kombiglyze) marketed by Bristol-Myers Squibb in partnership with Astrazeneca • Alogliptin (Nesina, Kazano & Oseni) marketed by Takeda Pharmaceuticals • Linagliptin (Tradjenta & Jentadueto) marketed by Eli Lilly and Boehringer Ingelheim While the drug industry continues to ignore or deny the existence… [read post]
23 May 2012, 1:15 am by Scott A. McKeown
(See page 24 of Eli Lilly statement explaining PGR estoppel drafting error here) It is expected that Congress will work toward fixing some of the above noted issues via a technical amendment. [read post]
18 Mar 2010, 10:25 am by Joe Consumer
  The case was over Eli Lilly's erectile “when the moment is right” dysfunction drug Cialis. [read post]
22 Dec 2007, 4:28 pm
Hood’s chief of staff, Geoffrey Morgan, added, “To my knowledge, Timothy Balducci has not handled any part of the Eli Lilly case since on or about Dec. 1, 2006, when he left the Langston Law Firm. [read post]
19 Mar 2008, 12:14 pm
In both Merck and Eli Lilly the [Supreme] Court stressed the congressional purpose of removing patent-based barriers to proceeding with federal regulatory approval of medical products. [read post]
16 Mar 2011, 1:21 pm by Ted Allen
 Coca-Cola Enterprises, AES, Newmont Mining, Lennar, Eli Lilly, Weyerhaeuser, Whirlpool, and Humana Inc. are among the large-cap firms that have endorsed annual votes in recent proxy filings. [read post]
30 Nov 2011, 3:45 pm by admin
The same year, Eli Lilly & Co. paid $1.4 billion in a settlement concerning sales of its Zyprexa anti-psychotic medicine. [read post]
3 May 2008, 5:16 am
    On the one hand, opponents of current patent law wonder if the law is too severe for what senior VP and general counsel for Eli Lilly calls "relatively minor acts of misconduct. [read post]
10 Jan 2013, 5:39 am by Joe Consumer
  So some cases have succeeded, and today we can report that four sisters with breast cancer and other severe reproductive problems in Boston, whose mother took DES, have forced Eli Lilly to settle their claims. [read post]
24 Nov 2010, 12:37 am by Kelly
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]